(Q36237707)

12 August 2017

1 reference

title

Nosocomial bacterial infections in Intensive Care Units. I: Organisms and mechanisms of antibiotic resistance (English)

1 reference

12 August 2017

1 reference

antibiotic resistance

1 reference

Lim SM

1

1 reference

12 August 2017

Webb SA

series ordinal

2

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

12 August 2017

number of pages

16

1 reference

based on heuristic

inferred from page(s)

published in

Anaesthesia

1 reference

12 August 2017

volume

60

1 reference

12 August 2017

issue

9

1 reference

12 August 2017

page(s)

887-902

1 reference

Infection control in the ICU.

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Nosocomial infections in the ICU: the growing importance of antibiotic-resistant pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Evaluation of outcome in critically ill patients with nosocomial enterobacter bacteremia: results of a matched cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Reappraisal of attributable mortality in critically ill patients with nosocomial bacteraemia involving Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Bacterial contamination of the hands of hospital staff during routine patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

The new threats of Gram positive pathogens: re-emergence of things past

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Increasing threat of Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Susceptibility testing with linezolid by different methods, in relation to published 'general breakpoints'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Antimicrobial susceptibility of coagulase-negative staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Vancomycin-resistant enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Antimicrobial susceptibility of Pseudomonas aeruginosa: results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Antibacterial resistance in the intensive care unit: mechanisms and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Efflux-mediated resistance to fluoroquinolones in gram-positive bacteria and the mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Of Pseudomonas, porins, pumps and carbapenems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Epidemiology of methicillin-resistant staphylococci in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Increasing threat of Gram-positive bacterial infections in the intensive care unit setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

New trends in Staphylococcus aureus infections: glycopeptide resistance in hospital and methicillin resistance in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Gram-positive resistance: challenge for the development of new antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Activity of quinupristin/dalfopristin against gram-positive bacteria: clinical applications and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Current and future management of infections due to methicillin-resistant staphylococci infections: the role of quinupristin/dalfopristin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Costs of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Linezolid resistance in a clinical isolate of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Vancomycin resistance in staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Coagulase-negative staphylococci: role as pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Pathogenesis of infections due to coagulase-negative staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Oxazolidinone antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Linezolid: the first oxazolidinone antimicrobial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

In vitro antistaphylococcal activity and testing of RP 59500, a new streptogramin, by two methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Vancomycin-resistant enterococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Prevalence of vancomycin-resistant enterococci in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Vancomycin-resistant enterococci: why are they here, and where do they come from?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Insights into the epidemiology and control of infection with vancomycin-resistant enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Antibiotic resistance among enterococci causing endocarditis in the UK: analysis of isolates referred to a reference laboratory

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Role of aminoglycosides in the treatment of bacterial endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Antimicrobial-drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Management of infections due to resistant enterococci: a review of therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Aminoglycoside resistance in enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Susceptibility to quinupristin/dalfopristin and other antibiotics of vancomycin-resistant enterococci from the UK, 1997 to mid-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin/dalfopristin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: comparison with a control cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Successful treatment of vancomycin-resistant enterococcus meningitis with linezolid: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1990-May 1999, issued June 1999. A report from the NNIS System

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Antimicrobial resistance in European isolates of Pseudomonas aeruginosa. European SENTRY Participants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Prescribing guidelines for severe Pseudomonas infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-June 2001, issued August 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04220.X

10.1111/J.1365-2044.2005.04220.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference